Showing results (31-40 of 285) with videos related to

Sort By:
Pageof 29
Contemporary Clinical Trials Communications|April 16, 2024
Transferring care to enhance access to early-phase cancer clinical trials: Protocol to evaluate a novel programChika Nwachukwu, Sukh Makhnoon, Marieshia Person, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2012
Metformin use is associated with better survival of diabetic patients with pancreatic cancerNavid Sadeghi, James L Abbruzzese, Sai-Ching J Yeung, et al.
Journal of Oncology Practice|April 10, 2019
Characteristics of Emergency Department Visits and Select Predictors of Hospitalization for Adults With Newly Diagnosed Cancer in a Safety-Net Health SystemArthur S Hong, Navid Sadeghi, Valorie Harvey, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Management and future directions in non-small cell lung cancer with known activating mutationsDavid E Gerber, Leena Gandhi, Daniel B Costa
The Lancet. Respiratory Medicine|June 2, 2018
Diagnosis and management of pulmonary toxicity associated with cancer immunotherapySawsan Rashdan, John D Minna, David E Gerber
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Beyond adenocarcinoma: current treatments and future directions for squamous, small cell, and rare lung cancer histologiesDavid E Gerber, Paul K Paik, Afshin Dowlati
Clinical Pharmacology : Advances and Applications|April 15, 2015
Expanding antitumor therapeutic windows by targeting cancer-specific nicotinamide adenine dinucleotide phosphate-biogenesis pathwaysGaurab Chakrabarti, David E Gerber, David A Boothman
Lung Cancer (Amsterdam, Netherlands)|March 19, 2013
Impact of renal function on treatment options and outcomes in advanced non-small cell lung cancerBercin Kutluk Cenik, Han Sun, David E Gerber
Immunotherapy|August 17, 2011
Development of bavituximab, a vascular targeting agent with immune-modulating properties, for lung cancer treatmentPaul DeRose, Philip E Thorpe, David E Gerber
Acta Haematologica|September 9, 2025
Patient Characteristics and Outcomes of Nodular Lymphocyte-Predominant Hodgkin's Lymphoma at a Safety-Net System Compared to an Academic Comprehensive Cancer CenterLuise Froessl, Theo Sottero, L Steven Brown, et al.
Pageof 29